Article1 January 1936STUDIES IN MULTIPLE SCLEROSISVIII. ETIOLOGIC FACTORS IN MULTIPLE SCLEROSIS*TRACY J. PUTNAM, M.D.TRACY J. PUTNAM, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-9-7-854 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTHE EXPERIMENTAL PRODUCTION OF LESIONS SIMULATING MULTIPLE SCLEROSISIn previous communications, it has been pointed out that lesions closely resembling typical plaques of multiple sclerosis may be produced in animals in either of two ways: by the subcutaneous injection of minute doses of tetanus toxin1and by experimental obstruction of cerebral venules.2In each case sclerotic lesions could be demonstrated only after an interval of several months from the original injury. The earlier lesions closely resembled those of "post-infectious encephalomyelitis," a disease occasionally seen following measles3and vaccinia4and often without obvious antecedent. Areas of demyelination, with relative persistence of...References1. PUTNAMMCKENNAEVANS TJJBJ: Experimental multiple sclerosis in dogs from injection of tetanus toxin, Jr. f. Psychol. u. Neurol., 1932, iv, 460-467. Google Scholar2. PUTNAM TJ: "Encephalitis" and sclerotic plaques from experimental venular obstruction, Arch. Neurol. and Psychiat. (In press.) Google Scholar3. FERRAROSCHEFFER AJH: Encephalitis and encephalomyelitis in measles: a pathologic report of six cases, Arch. Neurol. and Psychiat., 1931, xxv, 748-782. CrossrefGoogle Scholar4. HASSINGEIGER GBJP: Postvaccinal (cowpox) encephalitis, Arch. Neurol. and Psychiat., 1930, xxiii, 481-493. CrossrefGoogle Scholar5. MEYER H: Experimentelle Erfahrungen über die Kohlenoxydvergiftung des Zentralnervensystems, Ztschr. f. d. ges. Neurol. u. Psychiat., 1928, cxii, 187-212. CrossrefGoogle Scholar6. FERRARO A: Experimental toxic encephalomyelopathy, Psychiat. Quart., 1933, vii, 267-283. CrossrefGoogle Scholar7. PETTE H: Infektion und Nervensystem, Deutsch. Ztschr. f. Nervenh., 1929, cx, 221-289. CrossrefGoogle Scholar8. HASSINBASSOE GBP: Multiple degenerative softening versus multiple sclerosis, Arch. Neurol. and Psychiat., 1922, vii, 613-628. CrossrefGoogle Scholar9. WERTHAM F: Small foci of demyelinization in the cortex and spinal cord in diffuse sclerosis—their similarity to those of disseminated sclerosis and dementia paralytica, Arch. Neurol. and Psychiat., 1932, xxvii, 1380-1401. CrossrefGoogle Scholar10. PUTNAM TJ: Studies in multiple sclerosis. VII. Similarities between some forms of "encephalomyelitis" and multiple sclerosis, Arch. Neurol. and Psychiat. (In press.) Google Scholar11. WALTHARD KM: Spätstadium einer "Encephalitis" nach Masern, Ztschr. f. d. ges. Neurol. u. Psychiat., 1930, cxxiv, 176-193. CrossrefGoogle Scholar12. CRAMER A: Beginnende multiple Sklerose und akute Myelitis, Arch. f. Psychiat., 1888, xix, 667-683. CrossrefGoogle Scholar13. SCHLESINGER H: Zur Frage der akuten multiplen Sklerose und der Encephalomyelitis disseminata im Kindesalter, Arb. a. d. neurol. Inst. a. d. Wien Univ., 1909, xvii, 410-434. Google Scholar14. CESTANRISERPLANQUES : De la neuromyelite optique, Rev. Neurol., 1934, xli, 741-762. Google Scholar15. WOHLWILL F: Zwei seltene Komplikationen bei multipler Sklerose, Jr. f. Psychol. u. Neurol., 1928, xxxvii, 408. Google Scholar16. PUTNAMMCKENNAMORRISON TJJBLR: Studies in multiple sclerosis. I. The histogenesis of experimental sclerotic plaques and their relation to multiple sclerosis, Jr. Am. Med. Assoc., 1931, xcvii, 1591-1595. CrossrefGoogle Scholar17. CONEBARRERA WEE: The brain and the spinal fluid in acute aseptic cerebral embolism, Arch. Neurol. and Psychiat., 1931, xxv, 523-547. CrossrefGoogle Scholar18. RIVERS T: Filterable viruses (edited by Rivers), 1928, Williams and Wilkins, Baltimore. (See especially Chapter I by Rivers and Chapter IV by Cowdry.) Google Scholar19. DE RENYI GS: The structure of cells in tissues as revealed by microdissection. II. The physical properties of the living axis cylinder in the myelinated nerve fiber of the frog, Jr. Comp. Neurol., 1929, xlvii, 405-425. CrossrefGoogle Scholar20. HILPERT P: Kohlenoxydvergiftung und multiple Sklerose, Arch. f. Psychiat., 1929, lxxxix, 117-130. Google Scholar21. GLOBUSSTRAUSS JHI: Progressive degenerative subcortical encephalopathy, Arch. Neurol. and Psychiat., 1928, xx, 1190-1228. CrossrefGoogle Scholar22. WILLIAMSON JB: The early pathological changes in disseminated sclerosis, Manchester Med. Chron., 1894, xix, 373. Google Scholar23. RIBBERT H: Über multiple Sklerose des Gehirns und Rückenmarks, Arch. f. path. Anat. u. Physiol., 1882, xc, 243. CrossrefGoogle Scholar24. BORST : Die multiple Sklerose des Zentralnervensystems, Ergebn. d. allg. Pathol. u. path. Anat., 1903-1904, ix, 67. Google Scholar25. HASSIN GB: Studies in the pathogenesis of multiple sclerosis, Arch. Neurol. and Psychiat., 1922, vii, 589-607. CrossrefGoogle Scholar26. KREIDER PG: Measles encephalomyelopathy with venous thrombosis. (To appear.) Google Scholar27. VON HOESSLIN R: Über multiple Sklerose: Exogene Aetiologie, Pathogenese und Verlauf, 1934, Lehmann, München. Google Scholar28. BRICKNER RM: Studies on the pathogenesis of multiple sclerosis, Arch. Neurol. and Psychiat., 1930, xxiii, 715-726. CrossrefGoogle Scholar29. MCKENNA JB: The incidence of fever and leukocytosis in multiple sclerosis, Arch. Neurol. and Psychiat., 1930, xxiv, 542-549. CrossrefGoogle Scholar30. SOLOMONSIMON PB: The blood coagulation in multiple sclerosis (abstract only), Jr. Nerv. and Ment. Dis., 1935, lxxxi, 69. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication October 3, 1935. (Presented before the Section of Nervous and Mental Diseases of the American Medical Association, Atlantic City, June 12, 1935.)From the Neurological Unit, Boston City Hospital and the Department of Neurology, Harvard Medical School, Boston, Massachusetts.The expenses of this investigation were defrayed in part by the Multiple Sclerosis Fund of Harvard University. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByBEHAVIOUR OF BLOOD-PLATELETS IN MULTIPLE SCLEROSISMultiple SkleroseBLOOD COAGULATION STUDIES AND SEROTONIN DETERMINATIONS IN SERUM AND CEREBROSPINAL FLUID IN MULTIPLE SCLEROSISDiagnosis of Multiple SclerosisManagement of Multiple SclerosisData on the Pathology of Disseminated SclerosisThe Blood Supply of the Optic Nerve and Its Clinical SignificanceSUPRAVITAL ANALYSIS OF DISORDERS IN THE CEREBRAL VASCULAR PERMEABILITY II. TWO CASES OF MULTIPLE SCLEROSIS 1 January 1936Volume 9, Issue 7Page: 854-863KeywordsEncephalomyelitisLesionsMultiple sclerosisNeurologySubcutaneous injectionsTetanus Issue Published: 1 January 1936 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Tracy J. Putnam (1936) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: